PEDIATRICS Vol. 111 No. 4 April 2003, pp. e382-e387
ELECTRONIC ARTICLE |
Epidemiology of Chronic Renal Failure in Children: Data From the ItalKid Project
* Unit of Pediatric Nephrology, Dialysis and Transplantation, Department of Pediatrics, Milano, Italy
Unit of Pediatric Nephrology, OIRM, Torino, Italy
Epidemiology Unit, IRCCS Ospedale Maggiore, Milano, Italy
--> Objective. The ItalKid Project is a prospective, population-based registry that was started in 1990 with the aim of assessing the epidemiology of childhood chronic renal failure (CRF), describing the natural history of the disease, and identifying factors that influence its course. This article reports the epidemiologic results.
Methods. Prevalent and incident cases of CRF in children and adolescents were identified throughout Italy (total population base: 16.8 million children) by regularly asking all of the pediatric hospitals and adult nephrology units potentially involved in caring for children with kidney disease to report all cases that meet the inclusion criteria and then to update the clinical information regarding all previously reported patients on an annual basis. The inclusion criteria were 1) creatinine clearance (Ccr; according to Schwartz’s formula) <75 mL/min/1.73m2 bsa (predialysis) and 2) an age of <20 years at the time of registration.
Results. By December 31, 2000, 1197 patients (803 boys) had been registered. The mean incidence was 12.1 cases per million (range: 8.8–13.9), and the (point) prevalence was 74.7 per million of the age-related population. The mean age at registration was 6.9 ± 5.4 years, and the mean Ccr was 41.7 ± 20.5 mL/min/1.73 m2. The leading causes of CRF were hypodysplasia associated with urinary tract malformations (53.6%) and isolated hypodysplasia (13.9%), whereas glomerular disease accounted for as few as 6.8%. Hypodysplasia associated with primary vesicoureteral reflux (VUR) alone was responsible for as many as 25.8% of the cases, thus being the leading single cause with a female-to-male ratio of 1:3.2. The diagnosis of VUR was established early in life at an overall median age of 3 months (range: 0–180). However, the diagnosis was made significantly later among girls, whose median age at diagnosis was 9 months (range: 0–156; 95% confidence interval: 21.2–49.3) as against 2 months among boys (range: 0–180; 95% confidence interval: 10.9–21.2). As many as 23.6% of the registered patients had at least 1 severe associated disease (excluding urological abnormalities). A steep decline in renal survival occurred during puberty and early postpuberty, leading almost 70% of the patients to end-stage renal failure by the age of 20 years. When the population was subdivided on the basis of Ccr at the time of registration, the probability of kidney survival at 20 years of age was significantly different, being 63% in patients with mild renal failure (Ccr 51–75 mL/min), 30% in those with moderate renal failure (Ccr 25–50 mL/min), and 3% in those with severe renal failure (Ccr <25 mL/min). The incidence of renal replacement therapy was 7.3/y/100 patients, and the case-fatality rate on conservative treatment was 1.41%.
Conclusions. This study provides important and recent epidemiologic information concerning CRF in children and adolescents: a mean annual incidence of 12.1 new patients per million of the age-related population with a very high proportion (57.6%) of hypodysplastic renal diseases with or without urinary tract malformation. By the age of 20 years, the cumulative probability of end-stage renal disease in the population as a whole was 68%. The probability of kidney survival sharply declined during puberty and early postpuberty. This is the first prospective evaluation of the incidence and outcome of CRF in children, including those with mild and moderate renal impairment.
Key Words: kidney disease • renal failure • children • adolescents • epidemiology • vesicoureteral reflux
Abbreviations: CRF, chronic renal failure • ESRD, end-stage renal disease • NCC, national coordinating center • Ccr, creatinine clearance • sCr, serum creatinine • marp, million of the age-related population • VUR, vesicoureteral reflux • RRT, renal replacement therapy
Received for publication Dec 26, 2001; Accepted Nov 26, 2002.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  P. L. Weng, S. Sanna-Cherchi, T. Hensle, E. Shapiro, A. Werzberger, G. Caridi, C. Izzi, A. Konka, A. C. Reese, R. Cheng, et al. A Recessive Gene for Primary Vesicoureteral Reflux Maps to Chromosome 12p11-q13 J. Am. Soc. Nephrol., July 1, 2009; 20(7): 1633 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Wong, C. B. Pierce, S. R. Cole, B. A. Warady, R. H.K. Mak, N. M. Benador, F. Kaskel, S. L. Furth, G. J. Schwartz, and on behalf of the CKiD investigators Association of Proteinuria with Race, Cause of Chronic Kidney Disease, and Glomerular Filtration Rate in the Chronic Kidney Disease in Children Study Clin. J. Am. Soc. Nephrol., April 1, 2009; 4(4): 812 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zaffanello, M. Brugnara, M. Cecchetto, R. Manfredi, M. Zuffante, and V. Fanos Paediatric unilateral giant hydroureteronephrosis from idiopathic ureterovesical stricture: a case report BMJ Case Reports, February 27, 2009; 2009(feb26_1): bcr0820080782 - bcr0820080782. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Bertoli-Avella, M. L. Conte, F. Punzo, B. M. de Graaf, G. Lama, A. La Manna, C. Polito, C. Grassia, B. Nobili, P. F. Rambaldi, et al. ROBO2 Gene Variants Are Associated with Familial Vesicoureteral Reflux J. Am. Soc. Nephrol., April 1, 2008; 19(4): 825 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sun, K. Devish, W. J. Langer, P. K. Carmines, and P. H. Lane Testosterone treatment promotes tubular damage in experimental diabetes in prepubertal rats Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1681 - F1690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dziarmaga, P.-A. Hueber, D. Iglesias, N. Hache, A. Jeffs, N. Gendron, A. MacKenzie, M. Eccles, and P. Goodyer Neuronal apoptosis inhibitory protein is expressed in developing kidney and is regulated by PAX2 Am J Physiol Renal Physiol, October 1, 2006; 291(4): F913 - F920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dziarmaga, M. Eccles, and P. Goodyer Suppression of Ureteric Bud Apoptosis Rescues Nephron Endowment and Adult Renal Function in Pax2 Mutant Mice J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1568 - 1575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sanna-Cherchi, A. Reese, T. Hensle, G. Caridi, C. Izzi, Y. Y. Kim, A. Konka, L. Murer, F. Scolari, R. Ravazzolo, et al. Familial Vesicoureteral Reflux: Testing Replication of Linkage in Seven New Multigenerational Kindreds J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1781 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Lane, J. Sun, K. Devish, and W. J. Langer Dissociation of renal TGF-{beta} and hypertrophy in female rats with diabetes mellitus Am J Physiol Renal Physiol, November 1, 2004; 287(5): F1011 - F1020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Murer, F. Addabbo, M. Carmosino, G. Procino, G. Tamma, G. Montini, W. Rigamonti, P. Zucchetta, M. Della Vella, A. Venturini, et al. Selective Decrease in Urinary Aquaporin 2 and Increase in Prostaglandin E2 Excretion Is Associated with Postobstructive Polyuria in Human Congenital Hydronephrosis J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2705 - 2712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 OTHER ARTICLES NOTED (25 Apr 2003 to 18 Jul 2003) Evid. Based Nurs., October 1, 2003; 6(4): e1 - 12. [Full Text]
|
|
